Eight RCTs were included in the analysis, which contained a pooled sample of 520 participants.
In the validity assessment, 5 trials achieved 2 points on the Jadad scale and 3 trials scored 1 point; the maximum possible score was 5 points.
Results from 5 RCTs measuring oesophageal re-bleeding revealed that the pooled RR between groups was not significant at 1.05 (95% confidence interval, CI: 0.67, 1.64, P=0.83), and there was no evidence of publication bias or significant heterogeneity (P=0.68) between the studies. No significant differences were noted for mortality amongst the 7 studies that reported this outcome, given that the RR was 0.99 (95% CI: 0.68, 1.44, P=0.96). Again, there was neither statistical heterogeneity across the studies (P=0.59), nor any publication bias. In terms of variceal obliteration, the pooled results from all 8 studies revealed no significant difference in the mean number of endoscopic sessions required. The RR was 0.23 (95% CI: 0.055, 0.51, P=0.11). However, significant heterogeneity was found amongst these studies (P=0.01).
The analysis of adverse events found no significant differences in perforation, infection, posthemostasis ulcer bleeding, or cardiopulmonary arrest. However, the incidence of oesophageal stricture formation was found to be higher with combination therapy (8.9) than with EBL alone (0.38%), and this difference was statistically significant.